NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Linda should also explain her dealings with the Chinese to shareholders. I have stated what would happen if a bad deal with big pharma happened with regard to my understanding of Direct and I believe the Chinese would be very interested. It seems that Linda now understands the leverage she has by hinting at future Chinese involvement if others refuse to get real. She is playing her cards right. Let's see what happens.

I wonder if there is a second Chinese card???

What do we know?
1- the “Cambridge Transaction” with Huawei Technologies Research & Development (UK) Limited.
2- Ms. Powers was (still is???) a Board member of the Chinese Biopharmaceutical Association.
3- Maybe (???) here is another link:
Linda powers is a shareholder of INmune Bio inc.

Beneficial owners of more than 5%:

Toucan Capital Fund III (8)

8 Linda Powers of Toucan Capital Fund III and has voting and investment control of the shares of the Company’s held by Toucan Capital Fund III, 4800 Montgomery Lane, Suite 801, Bethesda, MD 20814.

A significant shareholder of the Company is also the owner of various companies that conduct business with the Company, including Luminus Holdings, Inc. (“Luminus”), Novamune, and Advent Bioservices, Inc. (“Advent Bioservices”)
https://www.sec.gov/Archives/edgar/data/1711754/000164033418002253/inmune_s1a3.htm

INmune Bio Inc. is a clinical stage biotechnology company that is developing new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer.

Management:
Raymond J. Tesi, MD
CEO/CMO
David J. Moss
CFO
Professor Mark Lowdell, PhD
CSO/CMO

One of the directors:
J. Kelly Ganjei

Three months ago David J.Moss (CFO) was in China to make a deal with the Chinese.

David Moss
CFO & Co-Founder INmune Bio, Inc.
3mo
“History in the making. First China Merchant Bank US IPO Escrow Agreement”.

Navid Malik’s comment:

Navid Malik Executive Director at THE LIFE SCIENCES DIVISION LTD

“Congratulations David, RJ and team. Very well deserved!”

J. Kelly Ganjei’s comment (my comments:he is playing with words)

J. Kelly Ganjei likes.

J. Kelly Ganjei Chief Executive Officer; Chairman of the Board at Cognate BioServices, Inc.

"I see you had lunch with a potential investor. Nice. I'm guessing you both had the bamboo salad."
· 1 Reply

David Moss:

LOL Kelly. Look forward to seeing you in san diego. Have many more pics to show you if you're keen on meeting our investors...
https://www.linkedin.com/in/david-moss-4b705460/detail/recent-activity/

I saw that there were some problems lately with the NWBO website. Maybe they are updating for a Chinese version like this one: https://inmunebio.com/index.php/en/news-2/2018-2 (LOL)